Literature DB >> 21325273

VentX trans-activates p53 and p16ink4a to regulate cellular senescence.

Xiaoming Wu1, Hong Gao, Weixiong Ke, Martin Hager, Sheng Xiao, Michael R Freeman, Zhenglun Zhu.   

Abstract

Cell senescence is a process of irreversible arrest of cell proliferation and plays an important role in tumor suppression. Recent studies showed that Wnt inhibition is a trigger of cellular senescence. Using methods of reverse genetics, we recently identified VentX, a human homolog of the vertebrate Xenopus Vent family of homeobox genes, as a novel Wnt repressor and a putative tumor suppressor in lymphocytic leukemia. Here, we show that VentX is a direct transcriptional activator of p53-p21 and p16ink4a-Rb tumor suppression pathways. Ectopic expression of VentX in cancer cells caused an irreversible cell cycle arrest with a typical senescence-like phenotype. Conversely, inhibition of VentX expression by RNA interference ameliorated chemotherapeutic agent-induced senescence in lymphocytic leukemia cells. The results of our study further reveal the mechanisms underlying tumor suppression function of VentX and suggest a role of VentX as a potential target in cancer prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325273      PMCID: PMC3069469          DOI: 10.1074/jbc.M110.206078

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.

Authors:  M Omura-Minamisawa; M B Diccianni; A Batova; R C Chang; L J Bridgeman; J Yu; J Pullen; W P Bowman; A L Yu
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

Review 2.  Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids.

Authors:  Igor B Roninson; Milos Dokmanovic
Journal:  J Cell Biochem       Date:  2003-01-01       Impact factor: 4.429

3.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 4.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

5.  Compromised HOXA5 function can limit p53 expression in human breast tumours.

Authors:  V Raman; S A Martensen; D Reisman; E Evron; W F Odenwald; E Jaffee; J Marks; S Sukumar
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

6.  DNA damage is able to induce senescence in tumor cells in vitro and in vivo.

Authors:  Robert H te Poele; Andrei L Okorokov; Lesley Jardine; Jeffrey Cummings; Simon P Joel
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

7.  Molecular cloning of a human Vent-like homeobox gene.

Authors:  P A Moretti; A J Davidson; E Baker; B Lilley; L I Zon; R J D'Andrea
Journal:  Genomics       Date:  2001-08       Impact factor: 5.736

8.  A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.

Authors:  Clemens A Schmitt; Jordan S Fridman; Meng Yang; Soyoung Lee; Eugene Baranov; Robert M Hoffman; Scott W Lowe
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

9.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 10.  The RB and p53 pathways in cancer.

Authors:  Charles J Sherr; Frank McCormick
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

View more
  11 in total

1.  Homeobox Gene Deregulation: Impact on the Hallmarks of Cancer.

Authors:  Dhwani Haria; Honami Naora
Journal:  Cancer Hallm       Date:  2013-09-01

2.  Suppression of homeobox transcription factor VentX promotes expansion of human hematopoietic stem/multipotent progenitor cells.

Authors:  Hong Gao; Xiaoming Wu; Yan Sun; Shuanhu Zhou; Leslie E Silberstein; Zhenglun Zhu
Journal:  J Biol Chem       Date:  2012-07-12       Impact factor: 5.157

3.  The homeobox transcription factor VentX controls human macrophage terminal differentiation and proinflammatory activation.

Authors:  Xiaoming Wu; Hong Gao; Weixiong Ke; Roger W Giese; Zhenglun Zhu
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

4.  Homeobox transcription factor VentX regulates differentiation and maturation of human dendritic cells.

Authors:  Xiaoming Wu; Hong Gao; Ronald Bleday; Zhenglun Zhu
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

Review 5.  The molecular balancing act of p16(INK4a) in cancer and aging.

Authors:  Kyle M LaPak; Christin E Burd
Journal:  Mol Cancer Res       Date:  2013-10-17       Impact factor: 5.852

6.  Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21 and p16 in vascular endothelial cells.

Authors:  Josette M Douville; David Y C Cheung; Krista L Herbert; Teri Moffatt; Jeffrey T Wigle
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

Review 7.  An oncologist׳s friend: How Xenopus contributes to cancer research.

Authors:  Laura J A Hardwick; Anna Philpott
Journal:  Dev Biol       Date:  2015-02-19       Impact factor: 3.582

8.  Homeobox protein VentX induces p53-independent apoptosis in cancer cells.

Authors:  Hong Gao; Bin Wu; Yi Le; Zhenglun Zhu
Journal:  Oncotarget       Date:  2016-06-28

9.  The homeobox protein VentX reverts immune suppression in the tumor microenvironment.

Authors:  Yi Le; Hong Gao; Ronald Bleday; Zhenglun Zhu
Journal:  Nat Commun       Date:  2018-06-05       Impact factor: 14.919

Review 10.  Ventx Family and Its Functional Similarities with Nanog: Involvement in Embryonic Development and Cancer Progression.

Authors:  Shiv Kumar; Vijay Kumar; Wenchang Li; Jaebong Kim
Journal:  Int J Mol Sci       Date:  2022-03-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.